Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1975 Sep;12(3):564–570. doi: 10.1128/iai.12.3.564-570.1975

Cell-mediated immunity in guinea pigs to subunits derived from hepatitis B surface antigen.

G A Cabral, R Chairez, F Marciano-Cabral, M Suarez, G R Dreesman, J L Melnick, F B Hollinger
PMCID: PMC415324  PMID: 1165121

Abstract

Guinea pigs immunized wit- hepatitis B surface antigen (HBSAg), types adw and ayw, and with two polypeptides (400,000 and 24,000 molecular weight) developed cell-mediated immunity (CMI), as determined by radioimmunoassay. Peritoneal exudate (PE) cells from guinea pigs immunized with the 40,000-molecular-weight polypeptide migrated poorly (30 to 88% inhibition) after challenge with the immunizing subunit or with purified HBSAg, type gdw or ayw. Response of the same PE cells to the 24,000-molecular-weight subunit was significantly reduced. Similar but less striking evidence for CMI was observed was PE cells derived from guinea pigs inoculated with purified type-specific HBSAg or with the 24,000-molecular-weight polypeptide. Humoral responses were predictable and showed a reasonable degree of correlation with the CMI response. PE cells from control animals inoculated with normal human serum or polyacrylamide gel were not inhibited after challenge with purified preparations of HBSAg or with the 400,000-molecular-weight polypeptide, but did show CMI with their respective immunogens. In addition, PE cells from guinea pigs inoculated with normal human serum were inhibited from migrating after challenge with the 24,000-molecular-weight subunit, suggesting that the latter may contain an antigenic determinant related to a human serum protein.

Full text

PDF
564

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chairez R., Hollinger F. B., Brunschwig J. P., Dreesman G. R. Comparative biophysical studies of hepatitis B antigen, subtypes adw and ayw. J Virol. 1975 Jan;15(1):182–190. doi: 10.1128/jvi.15.1.182-190.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chairez R., Hollinger F. B., Melnick J. L., Dreesman G. R. Biophysical properties of purified morphologic forms of hepatitis B antigen. Intervirology. 1974;3(3):129–140. doi: 10.1159/000149749. [DOI] [PubMed] [Google Scholar]
  3. Chairez R., Steiner S., Melnick J. L., Dreesman G. R. Glycoproteins associated with hepatitis B antigen. Intervirology. 1973;1(3):224–228. doi: 10.1159/000148850. [DOI] [PubMed] [Google Scholar]
  4. David J. R., David R. R. Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators. Prog Allergy. 1972;16:300–449. [PubMed] [Google Scholar]
  5. Dreesman G. R., Chairez R., Suarez M., Hollinger F. B., Courtney R. J., Melnick J. L. Production of antibody to individual polypeptides derived from purified hepatitis B surface antigen. J Virol. 1975 Sep;16(3):508–515. doi: 10.1128/jvi.16.3.508-515.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dreesman G. R., Hollinger F. B., McCombs R. M., Melnick J. L. Alteration of hepatitis B antigen (HB Ag) determinants by reduction and alkylation. J Gen Virol. 1973 Apr;19(1):129–134. doi: 10.1099/0022-1317-19-1-129. [DOI] [PubMed] [Google Scholar]
  7. Dreesman G. R., Hollinger F. B., McCombs R. M., Melnick J. L. Production of potent anti-Australia antigen sera of high specificity and sensitivity in goats. Infect Immun. 1972 Feb;5(2):213–221. doi: 10.1128/iai.5.2.213-221.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dudley F. J., Giustino V., Sherlock S. Cell-mediated immunity in patients positive for hepatitis-associated antigen. Br Med J. 1972 Dec 30;4(5843):754–756. doi: 10.1136/bmj.4.5843.754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Figenschau K. J., Ulstrup J. C. Staphylococcal radioimmunoassay for hepatitis B antigen and antibody. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Jun;82(3):422–428. doi: 10.1111/j.1699-0463.1974.tb02346.x. [DOI] [PubMed] [Google Scholar]
  10. Hakomori S., Stellner K., Watanabe K. Four antigenic variants of blood group A glycolipid: examples of highly complex, branched chain glycolipid of animal cell membrane. Biochem Biophys Res Commun. 1972 Nov 15;49(4):1061–1068. doi: 10.1016/0006-291x(72)90320-8. [DOI] [PubMed] [Google Scholar]
  11. Irwin G. R., Jr, Hierholzer W. J., Jr, McCollum R. W. Delayed hypersensitivity to hepatitis-associated antigen in guinea pigs. J Infect Dis. 1972 Jan;125(1):73–76. doi: 10.1093/infdis/125.1.73. [DOI] [PubMed] [Google Scholar]
  12. Millman I., Hutanen H., Merino F., Bayer M. E., Blumberg B. S. Australia antigen: physical and chemical properties. Res Commun Chem Pathol Pharmacol. 1971 Jul-Sep;2(4):667–686. [PubMed] [Google Scholar]
  13. Neurath A. R., Prince A. M., Lippin A. Hepatitis B antigen: antigenic sites related to human serum proteins revealed by affinity chromatography. Proc Natl Acad Sci U S A. 1974 Jul;71(7):2663–2667. doi: 10.1073/pnas.71.7.2663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rao K. R., Vyas G. N. Hepatitis B antigen activity in protein subunits produced by sonicaation. Nat New Biol. 1973 Feb 21;241(112):240–241. doi: 10.1038/newbio241240a0. [DOI] [PubMed] [Google Scholar]
  15. Steiner S., Huebner M. T., Dreesman G. R. Major polar lipids of hepatitis B antigen preparations: evidence for the presence of a glycosphingolipid. J Virol. 1974 Sep;14(3):572–577. doi: 10.1128/jvi.14.3.572-577.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Vyas G. N., Ibrahim A. B., Rao K. R., Likhite V. In vitro transfer of cell-mediated immunity to hepatitis B antigen with RNA. Nature. 1974 Feb 8;247(5440):377–378. doi: 10.1038/247377a0. [DOI] [PubMed] [Google Scholar]
  17. Vyas G. N., Rao K. R., Ibrahim A. B. Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds. Science. 1972 Dec 22;178(4067):1300–1301. doi: 10.1126/science.178.4067.1300. [DOI] [PubMed] [Google Scholar]
  18. de Gast G. C., Houwen B., Nieweg H. O. Specific lymphocyte stimulation by purified, heat-inactivated hepatitis-B antigen. Br Med J. 1973 Dec 22;4(5894):707–709. doi: 10.1136/bmj.4.5894.707. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES